{"id":4730,"date":"2026-05-06T09:10:20","date_gmt":"2026-05-06T07:10:20","guid":{"rendered":"https:\/\/ksbbiotech.com\/?page_id=4730"},"modified":"2026-06-01T12:27:18","modified_gmt":"2026-06-01T10:27:18","slug":"fluorescence-amh","status":"publish","type":"page","link":"https:\/\/ksbbiotech.com\/zh\/fluorescence-amh\/","title":{"rendered":"\u6297\u7f2a\u52d2\u7ba1\u6fc0\u7d20\uff08AMH\uff09"},"content":{"rendered":"\t\t
PDB ID: 7L0J. Source: RCSB Protein Data Bank. For illustration purposes only.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
The VeriLumenTM<\/sup>\u00a0AMH Rapid Test is a fluorescence immunochromatographic assay\u00a0for the quantitative measurement of anti-M\u00fcllerian hormone (AMH) in human whole blood, plasma, or serum samples. AMH is a hormone produced by ovarian follicles and is widely used as a biomarker of ovarian reserve and reproductive function. The assay provides rapid quantitative results to support timely clinical evaluation in laboratory and point-of-care settings.<\/p> This test is mainly used in the clinical assessment of ovarian reserve capacity, supporting evaluation of reproductive potential and ovarian function. Quantitative AMH measurement may assist healthcare professionals in fertility assessment, assisted reproduction planning, and monitoring ovarian response when interpreted together with clinical findings and other hormonal evaluations.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t